|
IFIH1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.595950E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.190000E-02 |
| Normal-vs-Stage2 |
3.398500E-04 |
| Normal-vs-Stage3 |
5.075900E-02 |
| Normal-vs-Stage4 |
6.837800E-02 |
| Stage1-vs-Stage2 |
3.409600E-02 |
| Stage1-vs-Stage3 |
9.769000E-01 |
| Stage1-vs-Stage4 |
8.857800E-01 |
| Stage2-vs-Stage3 |
7.278300E-02 |
| Stage2-vs-Stage4 |
1.214200E-01 |
| Stage3-vs-Stage4 |
8.908200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.569530E-02 |
| Normal-vs-AfricanAmerican |
7.967000E-01 |
| Normal-vs-Asian |
3.614000E-01 |
| Caucasian-vs-AfricanAmerican |
2.646800E-01 |
| Caucasian-vs-Asian |
3.800400E-01 |
| AfricanAmerican-vs-Asian |
7.104400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.396220E-03 |
| Normal-vs-Female |
1.975640E-02 |
| Male-vs-Female |
9.200400E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.275630E-01 |
| Normal-vs-Age(41-60Yrs) |
1.805710E-02 |
| Normal-vs-Age(61-80Yrs) |
5.795500E-04 |
| Normal-vs-Age(81-100Yrs) |
8.399800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.263400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.493760E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.410200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.483000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.098800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.423000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.943040E-01 |
| Classical-VS-Follicular |
1.62991842245219E-12 |
| Classical-VS-Other |
3.990400E-02 |
| Classical-VS-Normal |
1.478360E-01 |
| Tall-VS-Follicular |
1.97355000000066E-05 |
| Tall-VS-Other |
1.919650E-02 |
| Tall-VS-Normal |
7.688400E-01 |
| Follicular-VS-Other |
9.578800E-01 |
| Follicular-VS-Normal |
2.07660000306475E-10 |
| Other-VS-Normal |
3.461500E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.778300E-04 |
| Normal-vs-N1 |
5.862100E-02 |
| N0-vs-N1 |
5.819400E-01 |
|
|
